The global Pediatric Neuroblastoma Treatment market size is projected to reach US$ 867.1 million by 2028, from US$ 596.2 million in 2021, at a CAGR of 5.0% during 2022-2028.

The primary drivers influencing the Pediatric Neuroblastoma Treatment market growth are the prevalence of neuroblastoma in children, as well as increasing research and development, and improved public awareness of cancer treatment choices.

On rare occasions, a gene mutation passed from father to kid causes neuroblastoma. It might manifest in the spinal cord, neck, chest, or belly as well as in nerves close to the backbone. Bulging eyes, anemia, weakness, a hard mass in the abdomen, weight gain, irritability, fever, an enlarged stomach, bone pain, under-eye circles, and elevated blood pressure are among the signs of neuroblastoma.

Pediatric Neuroblastoma Treatment Market

Pediatric Neuroblastoma Treatment Market Trends

The Pediatric Neuroblastoma Treatment market will expand as healthcare infrastructure, especially in poorer nations, improves. Another significant driver of market expansion is the high incidence of this illness. Governments are making efforts in this direction as well.

These factors are also increasing public knowledge of the ailment, which is causing the Pediatric Neuroblastoma Treatment market to expand as a result of the upward growth curve in demand for efficient therapies. The single factor that is expected to limit the market's ability to grow to its full potential over the course of the forecast period is the high price of such therapies and medications. In the market, conducting research and development is likewise an expensive venture.

The incrasing use of immunotherapy to treat Pediatric Neuroblastoma is expected to fuel the Pediatric Neuroblastoma Treatment market. Following a stem cell transplant, it is often utilized as a part of the treatment for kids with high-risk neuroblastoma. For four days straight, this medication is administered intravenously (IV) over a period of many hours. Typically, this is carried out once each month over the course of 5 cycles of treatment.

Additionally, the government's increased investments in R&D initiatives to build the pediatric medical infrastructure and the public's growing knowledge of pediatric neuroblastoma therapy are fueling the Pediatric Neuroblastoma Treatment market expansion.

Pediatric Neuroblastoma Treatment Market Scope and Market Share

Throughout the forecast period, North America is anticipated to lead the market as a whole. Some of the primary causes of its significant market share include the high prevalence of pediatric neuroblastoma in the region and the well-established healthcare infrastructure. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry expansion.

Pediatric Neuroblastoma Treatment Market Segment By Type

Immunotherapy
Chemotherapy
Others

Pediatric Neuroblastoma Treatment Market Segment By Application

Hospitals
Clinics
Others

Key Companies

United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Scope of Pediatric Neuroblastoma Treatment Market Report

Report Metric	Details
Report Name	Pediatric Neuroblastoma TreatmentMarket
The market size in 2021	USD 596.2Million
The revenue forecast in 2028	USD 867.1 Million
Growth Rate	CAGR 5.0%
Market size available for years	2022-2028
Forecast units	Value (USD)
Segments covered	Type, Application, Industry, Regions
Report coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. What would be the forecast period in the Pediatric Neuroblastoma Treatment Market report?

Ans. The forecast period in the Pediatric Neuroblastoma Treatment Market report is from 2022 to 2028.

2. How can I get chapter-wise report/company profiles of the Global Pediatric Neuroblastoma Treatment industry?

Ans. The Chapter-wise Pediatric Neuroblastoma Treatment market report can be obtained on from the Valuates Reports website. Also, 24*7 chat support and direct call services are provided to procure the chapter-wise report.

3. What are the Segments by type in the Pediatric Neuroblastoma Treatment Market report?

Ans. Immunotherapy, Chemotherapy, Others are the segments by type in Pediatric Neuroblastoma Treatment Market.

4. How big is the Pediatric Neuroblastoma Treatment Market?

Ans. Pediatric Neuroblastoma Treatment market size is projected to reach US$ 867.1 million by 2028, from US$ 596.2 million in 2021, at a CAGR of 5.0% during 2022-2028.

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Immunotherapy

1.2.3 Chemotherapy

1.2.4 Others

1.3 Market by Application

1.3.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2017-2028)

2.2 Pediatric Neuroblastoma Treatment Growth Trends by Region

2.2.1 Pediatric Neuroblastoma Treatment Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pediatric Neuroblastoma Treatment Historic Market Size by Region (2017-2022)

2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2028)

2.3 Pediatric Neuroblastoma Treatment Market Dynamics

2.3.1 Pediatric Neuroblastoma Treatment Industry Trends

2.3.2 Pediatric Neuroblastoma Treatment Market Drivers

2.3.3 Pediatric Neuroblastoma Treatment Market Challenges

2.3.4 Pediatric Neuroblastoma Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue

3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2017-2022)

3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2017-2022)

3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue

3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio

3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2021

3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served

3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service

3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Neuroblastoma Treatment Breakdown Data by Type

4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2017-2022)

4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2028)

5 Pediatric Neuroblastoma Treatment Breakdown Data by Application

5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2017-2022)

5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Pediatric Neuroblastoma Treatment Market Size (2017-2028)

6.2 North America Pediatric Neuroblastoma Treatment Market Size by Type

6.2.1 North America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)

6.2.2 North America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)

6.2.3 North America Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)

6.3 North America Pediatric Neuroblastoma Treatment Market Size by Application

6.3.1 North America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)

6.3.2 North America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)

6.3.3 North America Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)

6.4 North America Pediatric Neuroblastoma Treatment Market Size by Country

6.4.1 North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)

6.4.2 North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2017-2028)

7.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type

7.2.1 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)

7.2.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)

7.2.3 Europe Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)

7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Application

7.3.1 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)

7.3.2 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)

7.3.3 Europe Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)

7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Country

7.4.1 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)

7.4.2 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2017-2028)

8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type

8.2.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)

8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application

8.3.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)

8.4 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region

8.4.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2017-2028)

9.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type

9.2.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)

9.2.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)

9.2.3 Latin America Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)

9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Application

9.3.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)

9.3.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)

9.3.3 Latin America Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)

9.4 Latin America Pediatric Neuroblastoma Treatment Market Size by Country

9.4.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)

9.4.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2017-2028)

10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type

10.2.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)

10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application

10.3.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)

10.4 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country

10.4.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 United Therapeutics

11.1.1 United Therapeutics Company Details

11.1.2 United Therapeutics Business Overview

11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction

11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.1.5 United Therapeutics Recent Developments

11.2 Apeiron Biologics

11.2.1 Apeiron Biologics Company Details

11.2.2 Apeiron Biologics Business Overview

11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction

11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.2.5 Apeiron Biologics Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction

11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.3.5 Pfizer Recent Developments

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction

11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.4.5 Bayer Recent Developments

11.5 Baxter

11.5.1 Baxter Company Details

11.5.2 Baxter Business Overview

11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction

11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.5.5 Baxter Recent Developments

11.6 Cellectar Biosciences

11.6.1 Cellectar Biosciences Company Details

11.6.2 Cellectar Biosciences Business Overview

11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction

11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.6.5 Cellectar Biosciences Recent Developments

11.7 MacroGenics

11.7.1 MacroGenics Company Details

11.7.2 MacroGenics Business Overview

11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction

11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)

11.7.5 MacroGenics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cellectar Biosciences

MacroGenics Inc

China

India

List of Tables

Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Immunotherapy

Table 3. Key Players of Chemotherapy

Table 4. Key Players of Others

Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Region (2017-2022)

Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Region (2023-2028)

Table 11. Pediatric Neuroblastoma Treatment Market Trends

Table 12. Pediatric Neuroblastoma Treatment Market Drivers

Table 13. Pediatric Neuroblastoma Treatment Market Challenges

Table 14. Pediatric Neuroblastoma Treatment Market Restraints

Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Pediatric Neuroblastoma Treatment Revenue Share by Players (2017-2022)

Table 17. Global Top Pediatric Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2021)

Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service

Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2017-2022)

Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2023-2028)

Table 28. Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2017-2022)

Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2023-2028)

Table 32. North America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 34. North America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 35. North America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 36. North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 37. North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 38. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 39. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 40. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 41. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 42. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 43. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 44. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 45. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 46. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 47. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 48. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 49. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028) & (US$ Million)

Table 50. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 51. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 52. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 53. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 54. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 55. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 62. United Therapeutics Company Details

Table 63. United Therapeutics Business Overview

Table 64. United Therapeutics Pediatric Neuroblastoma Treatment Product

Table 65. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 66. United Therapeutics Recent Developments

Table 67. Apeiron Biologics Company Details

Table 68. Apeiron Biologics Business Overview

Table 69. Apeiron Biologics Pediatric Neuroblastoma Treatment Product

Table 70. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 71. Apeiron Biologics Recent Developments

Table 72. Pfizer Company Details

Table 73. Pfizer Business Overview

Table 74. Pfizer Pediatric Neuroblastoma Treatment Product

Table 75. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 76. Pfizer Recent Developments

Table 77. Bayer Company Details

Table 78. Bayer Business Overview

Table 79. Bayer Pediatric Neuroblastoma Treatment Product

Table 80. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 81. Bayer Recent Developments

Table 82. Baxter Company Details

Table 83. Baxter Business Overview

Table 84. Baxter Pediatric Neuroblastoma Treatment Product

Table 85. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 86. Baxter Recent Developments

Table 87. Cellectar Biosciences Company Details

Table 88. Cellectar Biosciences Business Overview

Table 89. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product

Table 90. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 91. Cellectar Biosciences Recent Developments

Table 92. MacroGenics Company Details

Table 93. MacroGenics Business Overview

Table 94. MacroGenics Pediatric Neuroblastoma Treatment Product

Table 95. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)

Table 96. MacroGenics Recent Developments

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2021 VS 2028

Figure 2. Immunotherapy Features

Figure 3. Chemotherapy Features

Figure 4. Others Features

Figure 5. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2021 VS 2028

Figure 6. Hospitals Case Studies

Figure 7. Clinics Case Studies

Figure 8. Others Case Studies

Figure 9. Pediatric Neuroblastoma Treatment Report Years Considered

Figure 10. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Region: 2021 VS 2028

Figure 13. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2021

Figure 14. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2021

Figure 16. North America Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 17. North America Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)

Figure 18. North America Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)

Figure 19. North America Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)

Figure 20. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 23. Europe Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)

Figure 24. Europe Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)

Figure 25. Europe Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)

Figure 26. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Nordic Countries Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)

Figure 34. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)

Figure 35. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Share by Region (2017-2028)

Figure 36. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 43. Latin America Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)

Figure 44. Latin America Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)

Figure 45. Latin America Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)

Figure 46. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 49. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)

Figure 50. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)

Figure 51. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)

Figure 52. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. UAE Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 56. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 57. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 58. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 59. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 60. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 61. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Pediatric Neuroblastoma Treatment Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-28N1604

Global Pediatric Neuroblastoma Treatment Market Insights and Forecast to 2028

FEATURED COMPANIES

Pediatric Neuroblastoma Treatment Market Outlook - 2028

Pediatric Neuroblastoma Treatment Market Trends

Pediatric Neuroblastoma Treatment Market Scope and Market Share

Pediatric Neuroblastoma Treatment Market Segment By Type

Pediatric Neuroblastoma Treatment Market Segment By Application

Key Companies

By Region

Scope of Pediatric Neuroblastoma Treatment Market Report

Frequently Asked Questions About This Report

1. What would be the forecast period in the Pediatric Neuroblastoma Treatment Market report?

2. How can I get chapter-wise report/company profiles of the Global Pediatric Neuroblastoma Treatment industry?

3. What are the Segments by type in the Pediatric Neuroblastoma Treatment Market report?

4. How big is the Pediatric Neuroblastoma Treatment Market?

FEATURED COMPANIES

RELATED REPORTS